RecruitingNot applicableNCT05562505
Trial of Venovenous ECMO to De-Sedate, Extubate and Mobilise in Hypoxic Respiratory Failure
Studying Acute lung injury
Last synced from ClinicalTrials.gov
ℹ
Clinical trial records are synced from ClinicalTrials.gov through automated extraction.
Report missing dataKey facts
- Sponsor
- Australian and New Zealand Intensive Care Research Centre
- Principal Investigator
- Aidan Burrell, MBBSMonash University
- Intervention
- Venovenous ECMO(other)
- Enrollment
- 140 target
- Eligibility
- 18-65 years · All sexes
- Timeline
- 2022 – 2027
Study locations (7)
- St Vincent's Hospital Sydney, Darlinghurst, New South Wales, Australia
- Royal Prince Alfred, Sydney, New South Wales, Australia
- The Prince Charles Hospital, Brisbane, Queensland, Australia
- Gold Coast University Hospital, Gold Coast, Queensland, Australia
- The Alfred Hospital, Melbourne, Victoria, Australia
- Fiona Stanley Hospital, Perth, Western Australia, Australia
- Charite Universitatmedizin, Berlin, Germany
Collaborators
The Alfred
Primary source
Recruitment status, site addresses, contacts, and full eligibility criteria can change between syncs. Always verify with the trial team before planning travel or treatment.
Open NCT05562505 on ClinicalTrials.govOther trials for Acute lung injury
Additional recruiting or active studies for the same condition.
- RECRUITINGNANCT06526598Inspiratory Effort-Targeted Pressure Support Ventilation (IT-PSV) TrialCapital Medical University
- RECRUITINGNANCT07380789Comprehensive Multicenter Study on the Management of Acute Pain Following Thoracic Combat-Related Trauma in UkraineLviv National Medical University
- RECRUITINGPHASE2, PHASE3NCT07342205A Study on the Treatment of Patients With Acute Lung Injury Caused by Sepsis Through Microbiota TransplantationShanghai University of Traditional Chinese Medicine
- RECRUITINGPHASE3NCT07208591To Evaluate The Safety and Efficacy of STSA-1002 Injection in Patients With Acute Respiratory Distress SyndromeStaidson (Beijing) Biopharmaceuticals Co., Ltd
- RECRUITINGPHASE2NCT06513949Anti-CD14 Treatment With IC14 in Hospitalized ARDS PatientsImplicit Bioscience
- RECRUITINGPHASE2NCT06703073JUST BREATHE, Breathing Life Into Innovative Therapies for ARDS (Master Record)PPD Development, LP
- RECRUITINGPHASE1, PHASE2NCT07413978A Clinical Trial of Human Umbilical Cord Mesenchymal Stem Cell Injection for the Treatment of Severe Acute Respiratory Distress SyndromeChangchun Tuohua Pharmaceutical Co., Ltd.
- RECRUITINGNANCT06772025A Study to Understand How Cardiac Surgery-associated Acute Kidney Injury Develops in Participants Who Undergo Heart Surgery With the Use of Heart-lung MachineBayer